Published on 3/9/2022 in the Prospect News Emerging Markets Daily.
New Issue: Shanghai Fosun Pharma prices RMB 500 million 3½% four-year bonds
By Rebecca Melvin
New York, Feb. 3 – Shanghai Fosun Pharmaceutical (Group) Co., Ltd. issued RMB 500 million of 3½% four-year bonds, according to an announcement on Wednesday.
China Merchants Bank Co. Ltd. is the lead underwriter and Bank of Ningbo Co. Ltd. is joint lead underwriter.
The pharmaceutical company is a Shanghai-based member of the Hong Kong group Fosun International Ltd.
| Issuer: | Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
|
| Amount: | RMB 500 million
|
| Issue: | Corporate bonds, 2022 first tranche
|
| Maturity: | March 9, 2026
|
| Underwriters: | China Merchants Bank Co. Ltd. (lead) and Bank of Ningbo Co. Ltd.
|
| Coupon: | 3½%
|
| Price: | Par of RMB 100
|
| Settlement date: | March 9
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
